RED1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-86772
Key Product Details
Species Reactivity
Human, Mouse
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
1 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of human RED1. Peptide sequence: QLSNGGGGGPGRKRPLEEGSNGHSKYRLKKRRKTPGPVLPKNALMQLNEI The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for RED1 Antibody
Western Blot: RED1 Antibody [NBP2-86772]
Western Blot: RED1 Antibody [NBP2-86772] - WB Suggested Anti-ADARB1 Antibody Titration: 1.25ug/ml. ELISA Titer: 1:1562500. Positive Control: HepG2 cell lysateWestern Blot: RED1 Antibody [NBP2-86772]
Western Blot: RED1 Antibody [NBP2-86772] - ADARB1 antibody - N-terminal region validated by WB using Mouse brains at 1:1000.Applications for RED1 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: RED1
Alternate Names
ADAR2a, ADAR2ADAR2g, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, adenosine deaminase, RNA-specific, B1, double-stranded RNA-specific editase 1, DRABA2, DRADA2hRED1, EC 3.5, human dsRNA adenosine deaminase DRADA2, human dsRNA adenosine deaminase DRADA2b, EC 3.510adenosine deaminase, RNA-specific, B1 (homolog of rat RED1), RED1 homolog, RED1ADAR2d, RNA editase, RNA editing deaminase 1, RNA-editing deaminase 1, RNA-editing enzyme 1, RNA-specific, B1 (RED1 homolog rat)
Gene Symbol
ADARB1
Additional RED1 Products
Product Specific Notices for RED1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...